Favipiravir ameliorates bleomycin-induced pulmonary fibrosis by reprogramming M1/M2 macrophage polarization.
Zhang R, Jiang Q, Gao S, Zhang H, Xia Q, Liu B, Zhu J, Jiang H, Zhao R, Dong H, Li X, Zhang Y, Yang C, Gu X, Sun L, Zhou H.
Zhang R, et al. Among authors: sun l.
Int Immunopharmacol. 2024 Apr 20;131:111774. doi: 10.1016/j.intimp.2024.111774. Epub 2024 Mar 14.
Int Immunopharmacol. 2024.
PMID: 38489971